5:47 PM
 | 
Feb 14, 2013
 |  BC Extra  |  Company News

Fresenius halts pilot rollout of Affymax's Omontys

The Fresenius Medical Care unit of Fresenius SE & Co. KGaA (Xetra:FRE; NYSE:FSNUY) said it halted the rollout of a pilot program to assess anemia drug Omontys peginesatide from Affymax Inc. (NASDAQ:AFFY) in its dialysis centers. The...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >